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1  |  INTRODUC TION
Lichen planus (LP) is a chronic, inflammatory mucocutaneous disease 
that affects the skin, nails, scalp, and mucous membranes, especially the 
oral and the genital mucosa (Katta, 2000). The global prevalence of oral 
lichen planus (OLP) among clinical patients is around 1%, with a higher 
prevalence in African (1.43%) and South American (3.18%) populations 
(Li et al., 2020), while the prevalence of Diabetes Mellitus (DM) among 
OLP patients sways between 1.6% and 37.7% (Otero Rey et al., 2019).
OLP prevalence increases progressively with age and is three 
times higher after the age of 40 years (Gonzalez- Moles et al., 2020). 
OLP is associated with poorer quality of life and higher levels of anx-
iety and perceived stress (Daume et al., 2020; Radwan- Oczko et al., 
2018; Zucoloto et al., 2019).
OLP imposes a heavy burden on health costs (Ni Riordain et al., 
2016), and transforms to a malignant disease at a rate that varies be-
tween 1.09% (Fitzpatrick et al., 2014) and 2.28% (González- Moles 
et al., 2020). This malignant transformation rate is underestimated 
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Abstract
Objective: To undertake a meta- analysis of the association of Oral Lichen Planus 
(OLP) with diabetes, two diseases with an important impact on public health and the 
economy, but the evidence of which about their association is inconsistent.
Methods: Relevant studies were localized by searching MEDLINE, EMBASE, 
Conference Proceedings, and other databases from inception to October 2020, with-
out restrictions. The reference lists of included studies and of related reviews were 
also inspected. Global pooled odds ratios were calculated, and predefined subgroup 
analyses were performed. The heterogeneity between studies and publication bias 
was assessed and sensitivity analysis was carried out.
Results: Thirty- two studies were included in the meta- analysis. Pooled ORs showed 
a moderate association between diabetes and OLP [OR: 1.87 (95%CI: 1.57, 2.34)]. 
The association is limited to studies carried out on adults only [OR: 2.12 (95%CI: 1.75, 
2.57)] and is observed in all study designs. Globally, the heterogeneity was low to 
moderate. Studies carried out in European populations show a stronger association of 
diabetes and OLP than Asiatic studies [OR: 2.49 (95%CI: 1.87, 3.32) and 1.60 (95%CI: 
1.25, 2.03), respectively].
Conclusions: Diabetes and OLP are moderately associated. Systematic diagnosis of 
diabetes in OLP patients could prove useful.
K E Y W O R D S
diabetes mellitus, meta- analysis, Oral lichen planus
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(González- Moles et al., 2019). Indeed, 250 per 100,000 patients 
with DM have oral cancer (Ramos- Garcia et al., 2020). Experts call 
for the establishment of multi- center longitudinal studies with uni-
form diagnostic criteria to improve the identification of patients 
with oral premalignant diseases, including OLP (Warnakulasuriya 
et al.,2020).
The development of OLP has also been associated with sev-
eral comorbidities including hepatitis B and C infections, thyroid 
diseases, bowel diseases, metabolic syndromes like hypertension, 
dyslipidemia, and certain immunological disorders (DeAngelis et al., 
2019; Hasan et al., 2019; Nosratzehi, 2018).
The results of studies on the relation between DM and OLP are 
conflicting. While some studies suggested an increased risk of OLP 
in patients with DM, with a magnitude of association that varies con-
siderably between studies (Arduino et al., 2017; Nagao et al., 2005), 
others did not find any association between these diseases (Gerayli 
et al., 2015; Xue et al., 2005).
A meta- analysis was recently carried out on the relation of diabetes 
and oral potentially malignant disorders, including OLP (Ramos- Garcia 
et al., 2020). We aimed at completing and updating this meta- analysis.
2  |  MATERIAL S AND METHODS
2.1  |  Search strategy
Prisma guidelines were followed to retrieve relevant studies. 
Electronic search was carried out in the following databases: Medline, 
EMBASE, Conference Proceedings Citation Index- Science, the Open 
Access Theses and Dissertations, and the five regional bibliographic 
databases of the World Health Organization (WHO): African Index 
Medicus, Latin American and Caribbean Health Science Literature 
Database, Index Medicus for the Eastern Mediterranean Region, 
Index Medicus for South- East Asia Region and Western Pacific 
Region Index Medicus. The databases were searched from their in-
ception until October 2020. The following search terms were used 
in Medline without any language restriction: “(Oral Lichen Planus) 
AND (Diabetes)”, both in MeSH terms and free- text words. The 
search syntax was adapted for other databases and was completed 
by checking manually the reference lists of related reviews as well as 
those of studies retrieved electronically.
2.2  |  Studies selection
Retrieved titles and abstracts were scanned independently by two 
authors (NM and JS) for their potential inclusion in the meta- analysis. 
Potentially eligible studies were then selected, and their text was 
thoroughly reviewed to decide about their inclusion in the study. 
Discrepancies between reviewers were resolved by consensus.
Studies that met the following criteria were included: (1) ob-
servational epidemiological studies measuring the association be-
tween DM and OLP and reporting crude or adjusted Odds Ratio 
(OR), Relative Risk (RR) or Incidence Rate Ratio (IRR) and their 95% 
Confidence Interval (CI), or providing sufficient data for their cal-
culation, (2) studies that identified OLP cases following established 
clinical and/or histological criteria, (3) studies that presented a con-
trol or comparison group.
The exclusion criteria were studies (1) examining cutaneous LP 
or other extraoral locations that do not involve OLP, (2) not reporting 
sufficient data to calculate effect measures, 3) not reporting data on 
a comparison group.
The study protocol is registered in the International Prospective 
Register of Systematic Reviews (PROSPERO) (ID: CRD42020219080).
2.3  |  Data extraction
NM and PIV independently extracted the relevant data following 
a questionnaire that was designed for the purpose of the present 
meta- analysis. The extracted data encompassed: (1) study source: 
first author and year of publication; (2) setting: country, source of 
population (convenience sampling or well- defined source popula-
tion); (3) exposure ascertainment: method of DM determination 
(questionnaire, blood test, medical records); (4) type of DM (any 
type, type 1 or type 2); (5) outcome ascertainment: method of OLP 
diagnosis (clinical, histopathological); (6) study design: cohort, case- 
control or cross- sectional; (7) Adjustment for age and sex; and (8) 
measure of effect: reported OR, RR, IRR and their 95% CI or number 
of diabetic and non- diabetic OLP subjects and OLP- free comparison 
subjects to calculate these estimates.
2.4  |  Quality assessment
We used the Newcastle- Ottawa quality scale (NOS) in its original 
version for cohort and case- control studies (Wells et al., 2000), as 
well as in its version adapted to cross- sectional studies (Modesti 
et al., 2016). We assessed the risk of bias using the following sec-
tions: selection, comparability, exposure, and outcome. We scored 
each criterion 1 point or 0 points. The NOS appraisal of cohort and 
case- control studies is based on 8 items, while the version corre-
sponding to cross- sectional studies uses 7 items. We, therefore, 
computed a weighted total score to compare the quality of studies 
independently of their design, dividing the total score by the num-
ber of items of the scale. Studies with a weighted score >0.50 were 
considered as of higher quality, and those with a score ≤0.50 were 
deemed of lower quality. Details on the scoring system are available 
in Supplemental fileS1.
2.5  |  Data synthesis and statistical analysis
Pooled OR was obtained by using the inverse of variance of each 
study as a weight. ORs were considered unbiased estimates of 
the rate ratio (Rothman et al., 2008). When effect measures were 
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reported for type 1 and type 2 DM, they were pooled together to 
obtain an overall effect per study. Both fixed and random effects 
models were computed, but the random effects model estimates 
were used when heterogeneity was present. The heterogeneity 
between studies was evaluated by calculating Ri, the proportion 
of total variance due to between- study variance (Takkouche et al., 
1999). Ri values were interpreted as follows: low heterogeneity 
when Ri <0.4, moderate heterogeneity when Ri ranges between 0.4 
and 0.75, and high heterogeneity when Ri exceeds 0.75. Subgroup 
analyses were designed a priori. They involved study design, qual-
ity score, geographical location, exposure and outcome ascertain-
ment, type of diabetes, and control for confounding variables.
The presence of publication bias was explored visually using a 
funnel plot, and, more formally, using Egger´s regression test (Egger 
et al., 1997), and the Trim and Fill analysis (Duval & Tweedie, 2000).
As studies with a cross- sectional design are the most likely to 
be rejected if they present no association, sensitivity analysis was 
undertaken by considering that: (1) the published cross- sectional 
studies represent only half of the studies ever carried out and the 
other half was rejected, (2) the unpublished studies obtained a null 
association (OR = 1), and (3) the prevalence of OLP in the unpub-
lished studies was equal to the average prevalence of the published 
studies.
All analyses were carried out using HEpiMa version 2.1.3 (Costa- 
Bouzas et al., 2001), and Stata v 12 (Stata Corp).
3  |  RESULTS
3.1  |  Literature search and study characteristics
The literature search yielded 937 unique studies, 880 of which were 
excluded after the revision of titles and abstracts. Out of the 57 
publications selected for full- text review, 32 fulfilled the inclusion 
criteria and were included in the meta- analysis. Figure 1 represents 
the screening process and the motives of exclusion. The general 
characteristics and the identification of the included studies are 
presented in Table 1. The 32 included publications encompassed 
21 case- control studies, 10 cross- sectional studies, and one cohort 
study. One study was published in Croatian (Roguljić, 2017), one in 
German (Hornstein et al., 1984), and one in Persian (Mojabi et al., 
2009). The remainder were published in English.
3.2  |  Association between diabetes and OLP
Pooled OR from all studies revealed a moderate association be-
tween DM and OLP [OR: 1.87 (95%CI: 1.57, 2.22)], and a low degree 
of heterogeneity between studies was observed (Ri = 0.26) (Figure 2, 
Table 2).
The magnitude of association between DM and OLP was higher 
among cross- sectional studies [OR: 2.37 (95%CI: 1.60, 3.50)] 
F I G U R E  1  Flow diagram of the 
selection of studies about diabetes and 
oral lichen planus
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than among case- control studies [OR: 1.68 (95%CI: 1.38, 2.01)]. 
Heterogeneity was absent in cross- sectional studies (Ri = 0.001), 
and moderate in case- control studies (Ri = 0.34). The only cohort 
study, with a follow- up of 4 years, also reported a strong asso-
ciation between DM and OLP [OR: 6.40 (95%CI: 2.40, 17.60)] 
(Table 2).
TA B L E  1  Characteristics of studies included in the meta- analysis of oral lichen planus and diabetes mellitus
Source Country Age category
Diabetes 
type Diabetes ascertainment OLP ascertainment




DM- OLP- , DM+ OLP- , DM- OR (95%CI)
Cohort
Nagao et al., 2005 Japan Adults Any DM Questionnaire/ Interview Clinical & histological Yes - - - - - - - - - - - - 6.40 (2.4, 17.6)a 
Case- control
Dave et al., 2020 United States Adults Type 2 DM Blood test/ medical records Clinical & histological Yes 35 26 15 46 2.80 (1.20, 6.30)a 
Kats et al., 2019 Israel Adults Any DM Blood test/ medical records Clinical & histological Yes 4 98 5 97 0.79 (0.21, 3.04)
Zhou et al., 2018 China Adults Unspecified Unspecified Clinical & histological Yes 6 186 6 156 0.84 (0.27, 2.65)
Arduino et al., 2017 Italy Adults Unspecified Questionnaire/ Interview Clinical & histological Yes 36 271 14 228 2.16 (1.14, 4.11)
Roguljić, 2017 Croatia Adults Any DM Blood test/ medical records Clinical & histological No 4 3 59 60 1.36 (0.29, 6.32)
Bhattacharjee et al., 2016 India Adults Type 2 DM Questionnaire Clinical No 11 2 489 498 5.60 (1.24, 25.40)
Gerayli et al., 2015 Iran Adults Unspecified Blood test/ medical records Clinical & histological No 29 105 27 107 1.09 (0.61, 1.97)
Nagao & Sata, 2012 Japan Adults Any DM Questionnaire/ Interview Clinical & histological Yes 6 53 8 77 1.09 (0.36, 3.32)
Canjuga et al., 2010 Croatia Adults Any DM Blood test/ medical records Clinical & histological No 22 160 9 171 2.61 (1.17, 5.84)
Chalkoo, 2010 India Adults Any DM Blood test/ medical records Clinical & histological Yes 7 13 3 17 3.05 (0.66, 14.14)
Ali & Suresh, 2007 Saudi Arabia Adults Any DM Blood test/ medical records Clinical & histological Yes 14 26 6 34 3.05 (1.03, 9.02)
Seyhan et al., 2007 Turkey Children and adults Any DM Blood test/ medical records Clinical & histological Yes 8 22 1 29 10.55 (1.23, 90.66)
Xue et al., 2005 China Children and adults Unspecified Blood test/ medical records Clinical & histological No 78 596 10 68 0.89 (0.44, 1.80)
Denli et al., 2004 Turkey Children and adults Any DM Blood test/ medical records Clinical & histological No 22 238 20 260 1.20 (0.64, 2.26)
Machado et al., 2003 Brazil Adults Unspecified Unspecified Clinical & histological Yes 7 47 7 57 1.27 (0.41, 3.88)
Petrou- Amerikanou et al., 1998 Greece Adults Any DM Blood test/ Medical records Clinical & histological No 18 5 474 269 2.04 (0.75, 5.56)
Type 1 DM 8 5 131 269 3.29 (1.05, 10.24)
Type 2 DM 10 5 131 269 1.57 (0.53, 4.64)
Gorsky et al., 1996 Israel Adults Unspecified Blood test/ medical records Clinical & histological No 21 136 10 80 1.24 (0.55, 2.75)
Van Dis et al., 1995 USA Adults Type 1 DM Medical records Clinical Yes 11 8 262 265 1.39 (0.55, 3.51)
Borghelli et al., 1993 Argentine Children and adults Unspecified Unspecified Clinical No 4 6 725 670 0.62 (0.17, 2.19)
Hornstein et al., 1984 Germany Adults Unspecified Blood test/ medical records Clinical & histological Yes 53 124 21 156 3.18 (1.82, 5.55)
Lundström, 1983 Sweden Adults Any DM Blood test/ medical records Clinical & histological Yes 6 1 34 39 6.88 (0.79, 60.06)
Cross- sectional
Mohsin et al., 2014 Pakistan Unspecified Type 2 DM Unspecified Clinical & histological No 7 14 388 401 1.81 (0.53, 6.23)
Al- Maweri et al., 2013 Malaysia Adults Type 2 DM Blood test/ medical records Clinical & histological No 3 1 390 392 3.02 (0.31, 29.11)
López- Jornet et al., 2012 Spain Adults Unspecified Blood test/ medical records Clinical & histological Yes 25 175 8 192 3.43 (1.51, 7.80)
Saini et al., 2010 Malaysia Adults Any DM Blood test/ medical records Clinical & histological No 3 1 418 421 3.02 (0.31, 29.17)
Mojabi et al., 2009 Iran Adults Any DM Questionnaire/ Interview Clinical No 12 3 260 153 2.35 (0.65, 8.47)
Type 1 DM 7 3 141 153 2.53 (0.64, 9.98)
Type 2 DM 5 3 119 153 2.14 (0.50, 9.15)
Lundström, 2009 Sweden Children and adults Unspecified Medical records Clinical Yes 48 755 3 47 1.00 (0.30, 3.32)
Chung et al., 2004 Taiwan Adults Any DM Blood test/ medical records Clinical No 5 27 59 984 3.09 (1.15, 8.31)a 
Guggenheimer et al., 2000 USA Adults Type I DM Questionnaire Clinical No 2 2 403 266 1.52 (0.21, 10.82)
Zareei & Shirei, 2000 Iran Adults Any DM Unspecified Clinical & histological Yes 5 2 96 101 2.63 (0.50, 13.88)
Sallay et al., 1989 Hungary Adults Type 2 DM Blood test/ medical records Clinical & histological No 23 119 6 70 2.25 (0.88, 5.81)
Abbreviations: CI, confidence interval; DM, diabetes mellitus; DM- , subjects free from diabetes mellitus; DM+, subjects with diabetes mellitus; OLP,  
oral lichen planus; OLP- , subjects free from oral lichen planus; OLP+, subjects with oral lichen planus; OR, odds ratio.
areported OR and 95%CI. All OR and 95%CI were calculated in this meta- analysis except those marked with superscript lower- case 
letter a (a) that were extracted from the corresponding publication; and - - - : unavailable information.
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Eighteen studies were conducted in Asia, nine in Europe, three 
in North America, and two in South America. Stratifying the anal-
ysis by geographic location showed that the association between 
DM and OLP is stronger in the European studies [OR: 2.49 (95%CI: 
1.87, 3.32)] than in the Asian studies [1.60 (95%CI: 1.25, 2.03)]. The 
heterogeneity between studies was absent in the European studies 
TA B L E  1  Characteristics of studies included in the meta- analysis of oral lichen planus and diabetes mellitus
Source Country Age category
Diabetes 
type Diabetes ascertainment OLP ascertainment




DM- OLP- , DM+ OLP- , DM- OR (95%CI)
Cohort
Nagao et al., 2005 Japan Adults Any DM Questionnaire/ Interview Clinical & histological Yes - - - - - - - - - - - - 6.40 (2.4, 17.6)a 
Case- control
Dave et al., 2020 United States Adults Type 2 DM Blood test/ medical records Clinical & histological Yes 35 26 15 46 2.80 (1.20, 6.30)a 
Kats et al., 2019 Israel Adults Any DM Blood test/ medical records Clinical & histological Yes 4 98 5 97 0.79 (0.21, 3.04)
Zhou et al., 2018 China Adults Unspecified Unspecified Clinical & histological Yes 6 186 6 156 0.84 (0.27, 2.65)
Arduino et al., 2017 Italy Adults Unspecified Questionnaire/ Interview Clinical & histological Yes 36 271 14 228 2.16 (1.14, 4.11)
Roguljić, 2017 Croatia Adults Any DM Blood test/ medical records Clinical & histological No 4 3 59 60 1.36 (0.29, 6.32)
Bhattacharjee et al., 2016 India Adults Type 2 DM Questionnaire Clinical No 11 2 489 498 5.60 (1.24, 25.40)
Gerayli et al., 2015 Iran Adults Unspecified Blood test/ medical records Clinical & histological No 29 105 27 107 1.09 (0.61, 1.97)
Nagao & Sata, 2012 Japan Adults Any DM Questionnaire/ Interview Clinical & histological Yes 6 53 8 77 1.09 (0.36, 3.32)
Canjuga et al., 2010 Croatia Adults Any DM Blood test/ medical records Clinical & histological No 22 160 9 171 2.61 (1.17, 5.84)
Chalkoo, 2010 India Adults Any DM Blood test/ medical records Clinical & histological Yes 7 13 3 17 3.05 (0.66, 14.14)
Ali & Suresh, 2007 Saudi Arabia Adults Any DM Blood test/ medical records Clinical & histological Yes 14 26 6 34 3.05 (1.03, 9.02)
Seyhan et al., 2007 Turkey Children and adults Any DM Blood test/ medical records Clinical & histological Yes 8 22 1 29 10.55 (1.23, 90.66)
Xue et al., 2005 China Children and adults Unspecified Blood test/ medical records Clinical & histological No 78 596 10 68 0.89 (0.44, 1.80)
Denli et al., 2004 Turkey Children and adults Any DM Blood test/ medical records Clinical & histological No 22 238 20 260 1.20 (0.64, 2.26)
Machado et al., 2003 Brazil Adults Unspecified Unspecified Clinical & histological Yes 7 47 7 57 1.27 (0.41, 3.88)
Petrou- Amerikanou et al., 1998 Greece Adults Any DM Blood test/ Medical records Clinical & histological No 18 5 474 269 2.04 (0.75, 5.56)
Type 1 DM 8 5 131 269 3.29 (1.05, 10.24)
Type 2 DM 10 5 131 269 1.57 (0.53, 4.64)
Gorsky et al., 1996 Israel Adults Unspecified Blood test/ medical records Clinical & histological No 21 136 10 80 1.24 (0.55, 2.75)
Van Dis et al., 1995 USA Adults Type 1 DM Medical records Clinical Yes 11 8 262 265 1.39 (0.55, 3.51)
Borghelli et al., 1993 Argentine Children and adults Unspecified Unspecified Clinical No 4 6 725 670 0.62 (0.17, 2.19)
Hornstein et al., 1984 Germany Adults Unspecified Blood test/ medical records Clinical & histological Yes 53 124 21 156 3.18 (1.82, 5.55)
Lundström, 1983 Sweden Adults Any DM Blood test/ medical records Clinical & histological Yes 6 1 34 39 6.88 (0.79, 60.06)
Cross- sectional
Mohsin et al., 2014 Pakistan Unspecified Type 2 DM Unspecified Clinical & histological No 7 14 388 401 1.81 (0.53, 6.23)
Al- Maweri et al., 2013 Malaysia Adults Type 2 DM Blood test/ medical records Clinical & histological No 3 1 390 392 3.02 (0.31, 29.11)
López- Jornet et al., 2012 Spain Adults Unspecified Blood test/ medical records Clinical & histological Yes 25 175 8 192 3.43 (1.51, 7.80)
Saini et al., 2010 Malaysia Adults Any DM Blood test/ medical records Clinical & histological No 3 1 418 421 3.02 (0.31, 29.17)
Mojabi et al., 2009 Iran Adults Any DM Questionnaire/ Interview Clinical No 12 3 260 153 2.35 (0.65, 8.47)
Type 1 DM 7 3 141 153 2.53 (0.64, 9.98)
Type 2 DM 5 3 119 153 2.14 (0.50, 9.15)
Lundström, 2009 Sweden Children and adults Unspecified Medical records Clinical Yes 48 755 3 47 1.00 (0.30, 3.32)
Chung et al., 2004 Taiwan Adults Any DM Blood test/ medical records Clinical No 5 27 59 984 3.09 (1.15, 8.31)a 
Guggenheimer et al., 2000 USA Adults Type I DM Questionnaire Clinical No 2 2 403 266 1.52 (0.21, 10.82)
Zareei & Shirei, 2000 Iran Adults Any DM Unspecified Clinical & histological Yes 5 2 96 101 2.63 (0.50, 13.88)
Sallay et al., 1989 Hungary Adults Type 2 DM Blood test/ medical records Clinical & histological No 23 119 6 70 2.25 (0.88, 5.81)
Abbreviations: CI, confidence interval; DM, diabetes mellitus; DM- , subjects free from diabetes mellitus; DM+, subjects with diabetes mellitus; OLP,  
oral lichen planus; OLP- , subjects free from oral lichen planus; OLP+, subjects with oral lichen planus; OR, odds ratio.
areported OR and 95%CI. All OR and 95%CI were calculated in this meta- analysis except those marked with superscript lower- case 
letter a (a) that were extracted from the corresponding publication; and - - - : unavailable information.
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category (Ri = 0.001) and moderate in the Asian ones (Ri = 0.36) 
(Table 2).
Twenty- six studies were carried out in adults exclusively, and 
five studies involved a mixed population of children and adults. A 
strong association between DM and OLP was observed in the pop-
ulation of adults [OR: 2.12 (95%CI: 1.75, 2.57), while no association 
was observed in the subgroup of studies that involved a mixed pop-
ulation of children and adults [OR: 1.07 (95%CI: 0.71, 1.61)] (Table 2).
Most of the included studies (N = 23) did not specify the type 
of DM. The pooled OR estimate of these studies was similar to that 
obtained in the general analysis [OR: 1.81 (95% CI: 1.38, 2.38)]. 
Furthermore, a strong association was detected for type 2 DM stud-
ies [OR: 2.50 (95% CI: 1.63, 3.82)].
The majority of the studies (N = 22) ascertained the presence 
of diabetes using medical records and/or blood tests, whereas only 
five studies used questionnaires for this purpose. The remaining 
five studies did not report the method of diabetes ascertainment. 
Studies that relied on questionnaires showed a stronger association 
between DM and OLP [OR: 2.56 (95%CI: 1.63, 4.03)] than those that 
used medical records or blood tests [OR: 1.87 (95%CI: 1.53, 2.28].
Stratifying the analysis by quality score revealed a substantially 
stronger association between DM and OLP among studies of higher 
quality [OR: 2.99 (95%CI: 2.24, 4.00)] than among studies of lower 
quality [OR: 1.44 (95%CI: 1.16, 1.79)]. No heterogeneity was ob-
served in both subgroups of studies.
Half of the studies (N = 16) controlled for confounding from sex 
and age while the other half did not adjust for these factors. Studies 
adjusting for sex and age indicated a strong association between DM 
and OLP [OR: 2.32 (95% CI: 1.82, 2.97)]. The subgroup of studies 
that did not control for sex and age showed a weaker association 
between DM and OLP [OR: 1.52 (95%CI: 1.19, 1.93)].
3.3  |  Publication bias and sensitivity analysis
The visual examination of the funnel plot showed that the graph is 
slightly skewed to the right in the direction that favors the presence 
of association (Figure 3). Nonetheless, the Egger´s regression test 
did not confirm the presence of publication bias (p = 0.352).
The trim and fill analysis suggested the addition of two studies, 
but the corrected OR = 1.83 (95%CI: 1.54, 2.18), very close to our 
estimate, confirmed the presence of an association between DM 
and OLP. This association also withstood when pooled OR was re-
calculated under the extreme assumptions [OR: 1.14 (95%CI: 1.05, 
1.24)], confirming further the existence of an association between 
DM and OLP.
4  |  DISCUSSION
This meta- analysis shows that there is a moderate association be-
tween DM and OLP. This association was limited to adult patients, 
and it was observed in numerous study groups. A stronger association 
was detected in the European populations than in the Asian popula-
tions. In general, there was a low to moderate heterogeneity of effect 
between studies included in this meta- analysis. Our findings are not 
F I G U R E  2  Forest plot of the meta- 
analysis of diabetes and oral lichen 
planus
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easily ascribed to publication bias as shown in the analysis, and the 
association between the two diseases was robust even under extreme 
assumptions. Also, the association was of larger magnitude among 
studies with high quality than among studies with lower quality.
Our meta- analysis was updated and completed that carried out 
by Ramos- Garcia et al., (2020). We incorporated seventeen new 
studies, while 15 were already included in Ramos- Garcia's work. 
Some studies were excluded from our meta- analysis due to the lack 
of a control group or the presence of zero cell counts (e.g., zero un-
exposed cases) that yield undefined relative risk estimates. In spite 
of these large differences in the studies included, the global result 
is very similar in both meta- analyses. This demonstrates that the 
analysis of the relation of DM and OLP was robust to methodologic 
decisions.
The majority of the studies adequately ascertained the expo-
sure (DM) and the outcome (OLP) using medical records and histo-
pathological tests, respectively. Therefore, misclassification of the 
exposure or the outcome is unlikely to happen. In those studies in 
which diabetes antecedents are assessed through questionnaires, 
misclassification cannot be ruled out. However, this misclassifica-
tion is probably non- differential regarding OLP, that is, an errone-
ous diagnosis of diabetes occurs independently of the subsequent 
diagnosis of OLP. In a similar fashion, misclassification of OLP di-
agnosis may have occurred in those studies that lack histologic 
confirmation of this diagnosis. Again, had this error in the diagno-
sis of OLP occurred, it would have been independent of whether 
the subject is diabetic or not. In both cases of misclassification, 
the bias introduced, if any, is toward the null value. The true but 












All studies 32 1.87 (1.57, 2.22) 1.89 (1.53, 2.34) 0.26 0.10
Study design
Case- control 21 1.68 (1.38, 2.01) 1.68 (1.30, 2.17) 0.34 0.07
Cross- sectional 10 2.37 (1.60, 3.50) 2.37 (1.60, 3.50) 0.001 0.94
Cohort 1 6.40 (2.40, 17.60) - - - - - - - - - 
Location
Asia 18 1.60 (1.25, 2.03) 1.77 (1.28, 2.45) 0.36 0.07
Europe 9 2.49 (1.87, 3.32) 2.49 (1.87, 3.32) 0.001 0.72
Age category
Adults only 26 2.12 (1.75, 2.57) 2.12 (1.73, 2.61) 0.09 0.33
Adults and children 5 1.07 (0.71, 1.61) 1.09 (0.65, 1.82) 0.30 0.24
Type of diabetes
Unspecified/any 23 1.79 (1.47, 2.17) 1.81 (1.38, 2.38) 0.42 0.02
Type 1 4 1.77 (0.99, 3.14) 1.77 (0.99, 3.14) 0.001 0.91
Type 2 7 2.50 (1.63, 3.82) 2.50 (1.63, 3.82) 0.001 0.95
Diabetes ascertainment
Blood test/ medical records 22 1.87 (1.53, 2.28) 1.90 (1.50, 2.42) 0.24 0.16
Questionnaire 5 2.56 (1.63, 4.03) 2.66 (1.37, 5.15) 0.47 0.14
OLP ascertainment
Clinical and histological 26 1.85 (1.53, 2.22) 1.87 (1.47, 2.38) 0.33 0.06
Clinical only 6 2.02 (1.27, 3.21) 2.02 (1.27, 3.21) 0.001 0.48
Target population
Defined 5 2.90 (1.90, 4.44) 2.90 (1.90, 4.44) 0.001 0.46
Convenience sample 27 1.71 (1.42, 2.07) 1.72 (1.38, 2.16) 0.22 0.16
Quality score
Lower 22 1.44 (1.16, 1.79) 1.44 (1.16, 1.79) 0.001 0.70
Higher 10 2.99 (2.24, 4.00) 2.99 (2.24, 4.00) 0.001 0.44
Sex and age adjustment
Yes 16 2.32 (1.82, 2.97) 2.25 (1.65, 3.06) 0.29 0.14
No 16 1.52 (1.19, 1.93) 1.52 (1.19, 1.93) 0.001 0.45
aRi: Proportion of total variance due to between- study variance.
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unobserved association is then stronger than the one we observed 
in our results.
In spite of the strong association observed, so far, the biological 
mechanism implied in the relation between DM and OLP is still un-
known. A possible link between intake of hypoglycemic medicines 
in diabetic patients and occurrence of OLP has been hypothesized 
but was not confirmed further (Kaomongkolgit, 2010). Also, an in-
crease in the development of autoimmune diseases in patients with 
diabetes has been observed, which seems to indicate the existence 
of a general autoimmune disorder in these patients (Ramos- Garcia 
et al., 2020).
Worldwide, 9.3% of the population suffers from diabetes 
(Saeedi et al., 2019). Based on this prevalence and on our results, 
and assuming that the relation between both diseases is of causal 
nature, we estimate that more than 7% of OLP cases may be at-
tributable to diabetes among people with this disease (Rothman, 
1986).
Our meta- analysis has some limitations. The studies included 
in our meta- analysis were not adjusted for factors other than age 
and sex. Residual confounding may then have theoretically distorted 
our results, as occurs frequently in meta- analyses of observational 
studies. Although no factor, such as a genetic polymorphism, has 
been found to be a confounder of the relation between diabetes and 
OLP, we cannot rule out the existence of such a factor. However, 
the existence of an unidentified factor, of genetic nature or else, 
associated with both diabetes and OLP, which could explain a high 
proportion of the observed effect, is highly unlikely. Even if this po-
tential factor could double the risk of OLP among subjects exposed 
to it (OR confounder– disease =2) and, simultaneously, this factor 
happened to be twice more prevalent among diabetics than among 
non- diabetics (OR confounder– exposure =2), the adjusted OR of 
the relation diabetes- OLP would still be 1.66 (assuming one- third 
of people are exposed to this unknown factor) (Greenland, 1996). 
In line with this argument, it is worth mentioning that studies with 
age- and- sex adjustment yielded a stronger association than studies 
with no adjustment.
Furthermore, only one of the studies included in this meta- 
analysis used a cohort design. The large majority were assimilated 
to case- control studies but lacked the sophistication inherent to 
this design. In particular, the overwhelming majority used prevalent 
controls instead of incident ones. Furthermore, 27 out of 32 studies 
relied on convenience sampling (e.g., patients of a single consulta-
tion) and did not provide any target population to which the results 
could be generalized. Also, no lag time between diabetes onset and 
OLP occurrence was assessed. Therefore, we cannot rule out simul-
taneity between diabetes and OLP occurrence or reverse causation 
(i.e., OLP preceding diabetes). Indeed, recent reports indicate that 
the relation between DM and OLP may be reciprocal, that is, that 
one disease may be causally related with the other (Zhao et al., 
2019).
In conclusion, this meta- analysis shows that a moderate associa-
tion exists between DM and OLP. Future research should be based 
on prospective studies in which latency time between diagnosis of 
diabetes and occurrence of OLP is carefully assessed. Assessing DM 
among OLP patients could prove useful.
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